Cargando…

Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF

BACKGROUND AND AIMS: As a hepatocellular carcinoma biomarker, serum Golgi protein 73 (GP73) is reportedly related to inflammation. Acute-on-chronic liver failure (ACLF) is characterized by severe systemic inflammation. In this study, we aimed to explore the association between the GP73 level and sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Jingjing, Yao, Mingjie, Mu, Xiuying, Wang, Leijie, Wen, Xiajie, Zhai, Xingran, Xu, Xiang, Wang, Yu, Chen, Jing, Zhai, Xiangwei, Guan, Chongdan, Lu, Fengmin, Hu, Jinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240251/ https://www.ncbi.nlm.nih.gov/pubmed/35836755 http://dx.doi.org/10.14218/JCTH.2020.00133

Ejemplares similares

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
por: Wang, Leijie, et al.
Publicado: (2020)

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
por: Qian, Xiangjun, et al.
Publicado: (2019)

Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis
por: Yao, Mingjie, et al.
Publicado: (2022)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
por: Yang, Danli, et al.
Publicado: (2021)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

Use of serum Golgi protein 73 for screening chronic hepatitis B virus infection patients needing antiviral therapy in the community
por: Duan, Jinwei, et al.
Publicado: (2022)

A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients
por: Xia, Qi, et al.
Publicado: (2013)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
por: Seeßle, Jessica, et al.
Publicado: (2020)

Comparing CLIF-C ACLF, CLIF-C ACLF(lactate), and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
por: Kuo, Chao-Cheng, et al.
Publicado: (2021)

Golgi protein 73, hepatocellular carcinoma and other types of cancers
por: Wang, Yanan, et al.
Publicado: (2020)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma
por: Hu, Xinyang, et al.
Publicado: (2023)

Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis
por: YANG, JING, et al.
Publicado: (2015)

Application of serum Golgi protein-73 in the management of chronic liver disease
por: Yao, Ming-Jie, et al.
Publicado: (2021)

A new model for identification of HBV-related pre-ACLF
por: Jalan, Rajiv, et al.
Publicado: (2022)

Golgi protein 73 and its diagnostic value in liver diseases
por: Xia, Yanyan, et al.
Publicado: (2018)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

The creation of “Ecosystem Core” hypothesis to explain ecosystem evolution
por: Wang, Kun, et al.
Publicado: (2019)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients
por: Wang, Fei, et al.
Publicado: (2022)

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

Golgi protein 73 activation of MMP-13 promotes hepatocellular carcinoma cell invasion
por: Jin, Di, et al.
Publicado: (2015)

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
por: Liu, Fangfang, et al.
Publicado: (2020)

GP73, a novel Golgi-localized protein upregulated by viral infection
por: Kladney, Raleigh D., et al.
Publicado: (2000)

Evaluation of α-fetoprotein-L3 and Golgi protein 73 detection in diagnosis of hepatocellular carcinoma
por: Jia, Zhiling, et al.
Publicado: (2014)

Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF
por: Wu, Zhe-Bin, et al.
Publicado: (2021)

A Lower HCC Incidence in Chronic HBV-Infected Patients Recovered from Acute-on-Chronic Liver Failure: A Prospective Cohort Study
por: Yin, Jianhua, et al.
Publicado: (2022)

Mean arterial pressure drop is an independent risk factor of hepatorenal syndrome in patients with HBV-ACLF
por: Zheng, Xingrong, et al.
Publicado: (2022)

Severe acute hepatitis in children with unknown aetiology, etiology analysis and the next action
por: Gao, Yuan, et al.
Publicado: (2022)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF
por: Premkumar, Madhumita, et al.
Publicado: (2021)

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
por: Zhang, Xueyun, et al.
Publicado: (2022)

The Predictive Value of Golgi Protein 73 in Differentiating Benign from Malignant Liver Tumors
por: Bröker, Mirelle E. E., et al.
Publicado: (2014)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer
por: Xu, Zheng-Ju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_04dg0ku2bnhntp3sm1rt0377ls